Библиография

Открытие антител и начало пассивной иммунизации

Литература:

Heidelberger M. The soluble specific substance of pneumococcus / M. Heidelberger, O. T. Avery // The Journal of Experimental Medicine. – 1923. – Vol. 38, № 1. – P. 73–79.

Heidelberger M. The soluble specific substance of pneumococcus : second paper / M. Heidelberger, O. T. Avery // The Journal of Experimental Medicine. – 1924. – Vol. 40, № 3. – P. 301–317.

Heidelberger M. A quantitative study of the precipitin reaction between type III pneumococcus polysaccharide and purified homologous antibody / M. Heidelberger, F. E. Kendall // The Journal of Experimental Medicine. – 1929. – Vol. 50, № 6. – P. 809–823.

Ramón G. Sur l'augmentation anormale de l'antitoxine chez les chevaux producteurs de serum antidiptherique // Bulletin de la Societe du Centres Medicaux et Veterinaire. – 1925. – Vol. 101. – P. 227.

Janeway C. A. Use of concentrated human gamma globulin in the prevention and attenuation of measles // Bulletin of the New York Academy of Medicine. – 1945. – Vol. 21, № 4. – P. 202–222.

Hemophilus influenzae meningitis treated with streptomycin / H. E. Alexander, G. Leidy, G. Rake, R. Donovick // Journal of the American Medical Association. – 1946. – Vol. 132, № 8. – P. 434–440.

Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. IV. Final report of results based on clinical diagnoses / W. M. Hammon, L. L. Coriell, P. F. Wehrle, J. Stokes, Jr. // Journal of the American Medical Association. – 1953. – Vol. 151, № 15. – P. 1272–1285.

Kendrick D. B. Blood Program in World War II. – Washington, DC : Office of the Surgeon General, Dept. of the Army, 1964. – P. 922. – (Medical Department, United States Army, in World War II).

Köhler G. F. Continuous cultures of fused cells secreting antibody of predefined specificity / G. F. Köhler, C. Milstein // Nature. – 1975. – Vol. 256, № 5517. – P. 495–497.

EB virus-induced B lymphocyte cell lines producing specific antibody / M. Steinitz, G. Klein, S. Koskimies, O. Makel // Nature. – 1977. – Vol. 269, № 5627. – P. 420–422.

Lindenmann J. Origin of the terms «antibody» and «antigen» // Scandinavian Journal of Immunology. – 1984. – Vol. 19, № 4. – P. 281–285.

Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs / L. L. Green, M. C. Hardy, C. E. Maynard-Currie [et al.] // Nature Genetics. – 1994. – Vol. 7, № 1. – P. 13–21.

Casadevall A. Serum therapy revisited : animal models of infection and development of passive antibody therapy / A. Casadevall, M. D. Scharff // Antimicrobial Agents and Chemotherapy. – 1994. – Vol. 38, № 8. – P. 1695–1702.

Winau F. Emil von Behring and serum therapy / F. Winau, R. Winau // Microbes and infection. – 2002. – Vol. 4, № 2. – P. 185–188.

Predominant autoantibody production by early human B cell precursors / H. Wardemann, S. Yurasov, A. Schaefer // Science. – 2003. – Vol. 301, № 5638. – P. 1374–1377.

Meta-analysis : convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? / T. C. Luke, E. M. Kilbane, J. L. Jackson, S. L. Hoffman // Annals of internal medicine. – 2006. – Vol. 145, № 8. – P. 599–609.

Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors / Xiaocong Yu, T. Tsibane, P. A. McGraw [et al.] // Nature. – 2008. – Vol. 455, № 7212. – P. 532–536.

Rapid cloning of high-affinity human monoclonal antibodies against influenza virus / J. Wrammert, K. Smith, J. Miller [et al.] // Nature. – 2008. – Vol. 453, № 7195. – P. 667–671.